CLINICAL STUDIES

PROTOCOL NAMEDISEASE
NATIONAL COORDINATOR
FUNDING AUTHORITYCRO
1ALLIC-BFM 2022ACUTE LYMPHOBLASTIC LEUKEMIAPOLYCHRONOPOULOU SOPHIAFLOGACORONIS
2ALLIC RELAPSE 2022ACUTE LYMPHOBLASTIC LEUKEMIA - RELAPSEPOLYCHRONOPOULOU SOPHIANONO
3INTERFANT-2021INFANT LEUKEMIAAMPATZIDOU MIRELLA
FLOGACORONIS
4AEIOP-BFM-AML 2020ACUTE MYELOID LEUKEMIAPOLYCHRONOPOULOU SOPHIAFLOGACORONIS
5EWOG-MDS-JMML-SAAMYELODYSPLASTIC SYNDROMES (MDS), JMML, SAA, MPNPOLYCHRONOPOULOU SOPHIASUPPORTED BY FLOGANO
6International-CML-Ped StudyCHRONIC MYELOID LEUKEMIAAMPATZIDOU MIRELLANOT SUPPORTEDNO
7FAR-RMSRHABDOMYOSARCOMA (RMS)POURTSIDIS APOSTOLOSFLOGACORONIS
8MyKidsNON-RHABDOMYOSARCOMA SOFT TISSUE SARCOMAPOURTSIDIS APOSTOLOS--
9SIOPEN LINESLOW & INTERMEDIATE RISK NEUROBLASTOMAPAPADAKIS VASSILIOSFLOGACORONIS
10HR-NBL2HIGH-RISK NEUROBLASTOMAPAPADAKIS VASSILIOSFLOGACORONIS
11LCHLANGERHANS CELL HISTIOCYTOSISPAPADAKIS VASSILIOSARTEMIS ASSOCIATIONCORONIS
12UMBRELLARENAL TUMORSDOGANIS DIMITRIOSSUPPORTED BY FLOGANO
13EPENDYMOMA IIEPENDYMOMARIDOLA VITAFLOGACLEO
14i-EUROEWINGEWING SARCOMAKATZILAKIS NIKOLAOSFLOGACORONIS
15VERY RARE TUMORS - PARTNERVERY RARE TUMORSPOURTSIDIS APOSTOLOS--

Privacy Preference Center